{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:45:08Z","timestamp":1792511108702,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["818806"],"award-info":[{"award-number":["818806"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016015","name":"Universit\u00e4tsspital Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.103051","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:45:29Z","timestamp":1789483529000},"page":"103051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell tracking reveals tumor-reactive T cell plasticity during melanoma TIL therapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Michael T.","family":"Sandholzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Serger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia G.","family":"Liner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarp","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Thut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Ritschard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas D.","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zingg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1302-7013","authenticated-orcid":false,"given":"Natalia Rodrigues","family":"Mantuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kasenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Glatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.","family":"Kappos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Holbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Stenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7092-3351","authenticated-orcid":false,"given":"Jakob","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2642-419X","authenticated-orcid":false,"given":"Nina","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Jeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mascha","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Zippelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8910-5620","authenticated-orcid":false,"given":"Heinz","family":"L\u00e4ubli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103051_bib1","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMra2034861","article-title":"Recent Advances in the Treatment of Melanoma","volume":"384","author":"Curti","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103051_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103051_bib3","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/annonc\/mdz398","article-title":"Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis","volume":"30","author":"Dafni","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2026.103051_bib4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103051_bib5","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1200\/JCO.21.00612","article-title":"Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma","volume":"39","author":"Sarnaik","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103051_bib6","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa2210233","article-title":"Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma","volume":"387","author":"Rohaan","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.103051_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005755","volume":"10","author":"Chesney","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.103051_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/01.cji.0000158855.92792.7a","article-title":"Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression","volume":"28","author":"Huang","year":"2005","journal-title":"J. Immunother."},{"key":"10.1016\/j.xcrm.2026.103051_bib9","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103051_bib10","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI24480","article-title":"Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells","volume":"115","author":"Gattinoni","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103051_bib11","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1158\/2159-8290.CD-20-1677","article-title":"Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy","volume":"11","author":"Chen","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103051_bib12","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.abb9847","article-title":"Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer","volume":"370","author":"Krishna","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103051_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.aak9510","article-title":"Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer","volume":"356","author":"Stevanovi\u0107","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103051_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.3682","article-title":"'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations","volume":"18","author":"Tran","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-18-1494","article-title":"Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers","volume":"9","author":"Parkhurst","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103051_bib16","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1158\/1078-0432.CCR-19-3845","article-title":"The Outcome of Ex Vivo TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic In Vitro Growth Capacity between T-Cell Clones","volume":"26","author":"Poschke","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103051_bib17","article-title":"Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma","volume":"24","author":"K\u00f6nig","year":"2024","journal-title":"Immunooncol. Technol."},{"key":"10.1016\/j.xcrm.2026.103051_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008640","article-title":"Biomarkers for response to TIL therapy: a comprehensive review","volume":"12","author":"Albarr\u00e1n Fern\u00e1ndez","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.103051_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103051_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103051_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","article-title":"Phenotype, specificity and avidity of antitumour CD8(+) T cells in melanoma","volume":"596","author":"Oliveira","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103051_bib22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103051_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccell.2022.03.012","article-title":"A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers","volume":"40","author":"Hanada","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103051_bib24","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/j.immuni.2024.08.014","article-title":"Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma","volume":"57","author":"Chiffelle","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103051_bib25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.medj.2022.07.008","article-title":"Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade","volume":"3","author":"Palmer","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.xcrm.2026.103051_bib26","doi-asserted-by":"crossref","first-page":"116.3","DOI":"10.4049\/jimmunol.202.Supp.116.3","article-title":"CD300c is a negative regulator of T cell immunity","volume":"202","author":"Lai","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib27","article-title":"The role of CXCR3 and its ligands in cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2026.103051_bib28","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.1000094","article-title":"Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells","volume":"186","author":"Takada","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib29","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41590-025-02276-7","article-title":"Lymph nodes fuel KLF2-dependent effector CD8+ T cell differentiation during chronic infection and checkpoint blockade","volume":"26","author":"Tsui","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077537","article-title":"The impact of KLF2 modulation on the transcriptional program and function of CD8 T cells","volume":"8","author":"Preston","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.103051_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","article-title":"An intra-tumoral niche maintains and differentiates stem-like CD8 T cells","volume":"576","author":"Jansen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103051_bib32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103051_bib33","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.trecan.2024.07.009","article-title":"CD4+ T cells in antitumor immunity","volume":"10","author":"Montauti","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2026.103051_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1022136","article-title":"CXCR6 expressing T cells: Functions and role in the control of tumors","volume":"13","author":"Mabrouk","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4049\/jimmunol.2300250","article-title":"CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy","volume":"211","author":"Thompson","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccell.2022.09.011","article-title":"Technology meets TILs: Deciphering T cell function in the -omics era","volume":"41","author":"Hudson","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103051_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101797","article-title":"T follicular helper cells in cancer, tertiary lymphoid structures, and beyond","volume":"69","author":"Cui","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006264","article-title":"Cell surface marker-based capture of neoantigen-reactive CD8(+) T-cell receptors from metastatic tumor digests","volume":"11","author":"Chatani","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.103051_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8(+) T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.103051_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.15","article-title":"Clinical manufacturing of CAR T cells: foundation of a promising therapy","volume":"3","author":"Wang","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.xcrm.2026.103051_bib41","article-title":"Th17 Cells Paradoxical Roles in Melanoma and Potential Application in Immunotherapy","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib42","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway","volume":"206","author":"Wang","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.103051_bib43","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.3390\/cancers13236132","article-title":"Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity","volume":"13","author":"Matsuo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.103051_bib44","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.4110\/in.2020.20.e6","article-title":"IL-17-Producing Cells in Tumor Immunity: Friends or Foes?","volume":"20","author":"Kuen","year":"2020","journal-title":"Immune Netw."},{"key":"10.1016\/j.xcrm.2026.103051_bib45","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells","volume":"179","author":"Chen","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib47","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/eji.201041205","article-title":"TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40","volume":"41","author":"Hamano","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cyto.2013.09.008","article-title":"In vitro generated Th17 cells support the expansion and phenotypic stability of CD4+Foxp3+ regulatory T cells in vivo","volume":"65","author":"Zhou","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.xcrm.2026.103051_bib49","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1158\/0008-5472.CAN-19-3685","article-title":"IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to Tumors","volume":"80","author":"Knochelmann","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103051_bib50","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/blood-2005-06-2399","article-title":"IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients","volume":"107","author":"Ahmadzadeh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103051_bib51","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/nm1312","article-title":"Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103051_bib52","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1182\/blood-2011-10-386482","article-title":"Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer","volume":"119","author":"Yao","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103051_bib53","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2381891","article-title":"Discovery and development of ANV419, an IL-2\/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy","volume":"16","author":"Murer","year":"2024","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2026.103051_bib54","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103051_bib55","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1128\/JVI.75.24.12319-12330.2001","article-title":"Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs","volume":"75","author":"Browne","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.103051_bib56","unstructured":"Nazarov V., Tsvetkov V., Popov A., Balashov I. immunarch: Multi-Modal Immune Repertoire Analytics for Immunotherapy and Vaccine Design in R. R package version 0.10. 3."},{"key":"10.1016\/j.xcrm.2026.103051_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-3083.2011.02640.x","article-title":"Characterization and comparison of \u2018standard' and \u2018young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution","volume":"75","author":"Donia","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib58","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/annonc\/mdy139","article-title":"T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression","volume":"29","author":"Andersen","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2026.103051_bib59","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/CMR.0b013e3283390696","article-title":"Establishment of stable cell lines for personalized melanoma cell vaccine","volume":"20","author":"Selvan","year":"2010","journal-title":"Melanoma Res."},{"key":"10.1016\/j.xcrm.2026.103051_bib60","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3389\/fimmu.2020.01859","article-title":"Transcriptional Profiling of CD8+ CMV-Specific T Cell Functional Subsets Obtained Using a Modified Method for Isolating High-Quality RNA From Fixed and Permeabilized Cells","volume":"11","author":"Healy","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.103051_bib61","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.103051_bib62","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s43018-022-00433-7","article-title":"Single-cell meta-analyses reveal responses of tumor-reactive CXCL13(+) T cells to immune-checkpoint blockade","volume":"3","author":"Liu","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.103051_bib63","doi-asserted-by":"crossref","unstructured":"Ahlmann-Eltze, C., and Patil, I. (2021). Ggsignif: R Package for Displaying Significance Brackets For'ggplot2'.","DOI":"10.31234\/osf.io\/7awm6"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:05:53Z","timestamp":1792508753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666379126004684"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103051","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell tracking reveals tumor-reactive T cell plasticity during melanoma TIL therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103051"}}